Viewing nowCombinationAmloKande Tablet 8/2.5 mg (Candesartan Cilexetil, S-Amlodipine Besilate)
Candesartan Cilexetil 8mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Allico Pharmaceutical Co., Ltd.

MFDS item code 202503322 · Approved 2025.12.19
Treatment of essential hypertension not controlled with monotherapy
This medicine is used in patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy using either Candesartan Cilexetil or S-Amlodipine (Amlodipine). It helps effectively manage hypertension and reduce the risk of cardiovascular complications.
The recommended dose is 1 tablet once daily, taken with water with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended to adjust the dose using the individual components (candesartan cilexetil or S-amlodipine (amlodipine)). However, if blood pressure is not adequately controlled with monotherapy using the individual components, a direct switch to this medicine may be considered as follows. - 8/2.5 milligrams: For patients whose blood pressure is not adequately controlled with candesartan cilexetil 8 milligrams or S-amlodipine 2.5 milligrams (amlodipine 5 milligrams). - 16/2.5 milligrams: For patients whose blood pressure is not adequately controlled with candesartan cilexetil 16 milligrams or S-amlodipine 2.5 milligrams (amlodipine 5 milligrams). - 16/5 milligrams: For patients whose blood pressure is not adequately controlled with candesartan cilexetil 16 milligrams, S-amlodipine 5 milligrams (amlodipine 10 milligrams), or this medicine 16/2.5 milligrams. Patients taking candesartan cilexetil and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. • Patients with renal impairment: Since the recommended initial dose of candesartan cilexetil for patients with renal impairment is 4 milligrams once daily, it is not advisable to use this medicine as initial therapy. • Patients with hepatic impairment: Since the recommended initial dose of candesartan cilexetil for patients with mild or moderate hepatic impairment is 2 milligrams once daily, it is not advisable to use this medicine as initial therapy.
Adolescents and children 18 years of age or younger: Use of this medicine is not recommended because its safety and efficacy have not been established.
This medication may cause serious harm to the fetus and newborn in pregnant women, so it should be discontinued immediately if pregnancy is confirmed. This medication should not be administered to certain patients, including those with hypersensitivity to the drug, pregnant or breastfeeding women, patients with severe liver impairment, patients with diabetes or severe renal impairment, patients with a history of angioedema, patients with primary hyperaldosteronism, patients with severe aortic stenosis, and patients in a state of shock. Elderly patients, patients with hyperkalemia, patients with liver impairment, patients with hypotension, patients with heart valve diseases, patients with cardiovascular diseases, and patients with impaired kidney function should use this medication cautiously, and blood pressure, kidney function, and serum potassium levels should be checked periodically during treatment. This medication may cause various side effects like dizziness, headache, chest discomfort, edema, myalgia, skin rash, digestive symptoms, etc., and if any abnormal symptoms occur, consultation with a doctor or pharmacist is recommended. This medication may interact with other antihypertensive agents, diuretics, potassium-sparing diuretics, non-steroidal anti-inflammatory drugs, etc., so if other medications are being taken, it is essential to inform the prescribing doctor, especially considering the risk of elevated potassium levels. Pregnant or breastfeeding women should avoid the use of this medication, and if necessary, breastfeeding should be discontinued. This medication is not recommended for children or adolescents under 18 years of age, as safety and efficacy have not been established. In case of overdose, symptoms such as hypotension, dizziness, and tachycardia may occur, and immediate medical attention should be sought for appropriate treatment. This medication should be kept out of reach of children, and transferring it to another container should be avoided as it may risk quality degradation and accidents.
Not everyone experiences these, and they can vary from person to person.
The medication should be stored in a tightly sealed container to protect it from air and moisture. It is advisable to maintain a storage temperature between 1 and 30 degrees Celsius. This will help preserve the efficacy and safety of the medication for a long time.
White, biconvex, round film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationCandesartan Cilexetil 8mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Allico Pharmaceutical Co., Ltd.
CombinationCandesartan Cilexetil 8mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
CombinationCandesartan Cilexetil 16mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Myeongmun Pharmaceutical Co., Ltd.
CombinationCandesartan Cilexetil 16mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
CombinationCandesartan Cilexetil 8mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Hyundai Pharmaceutical Co., Ltd.
CombinationCandesartan Cilexetil 16mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Hyundai Pharmaceutical Co., Ltd.
CombinationCandesartan Cilexetil 16mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Hyundai Pharmaceutical Co., Ltd.
CombinationCandesartan Cilexetil 16mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Aliko Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.